Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744952 · ClinicalTrials.gov registry record
Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis
A clinical trial, sponsored by Peter Merkel.
- Completed
- Registry status
- 26
- Enrollment target
NCT00744952: Completed study, sponsored by Peter Merkel.
NCT00744952 is a clinical trial that has completed, run by Peter Merkel. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00744952 has completed, sponsored by Peter Merkel.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Assessing disease activity in people with Takayasu's arteritis is difficult, as most people with the disease do not exhibit visible, measurable symptoms. Combination positron emission tomography/computed axial tomography (PET/CT) is a particularly sensitive, accurate scanning method that may improve researchers' ability to evaluate people with the disease. This study will determine the effectiveness of PET/CT in assessing disease activity in people with Takayasu's arteritis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-08 |
| Est. Completion | 2018-09-30 |
What the finished NCT00744952 record still lists
NCT00744952 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00744952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00744952 about?
NCT00744952 is a clinical study titled "Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis". Assessing disease activity in people with Takayasu's arteritis is difficult, as most people with the disease do not exhibit visible, measurable symptoms. Combination positron emission tomography/computed axial tomography (PET/CT) is a particularly sensitive, accurate scanning method that may improve...
What is the current status of trial NCT00744952?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-08. Estimated completion is 2018-09-30.
Who is sponsoring clinical trial NCT00744952?
This trial is sponsored by Peter Merkel, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia